D-0849-2026 Class I Ongoing
FDA drug recall D-0849-2026 was initiated by Baxter Healthcare Corporation on August 17, 2026 and is designated Class I. Reason for recall: Presence of particulate matter: Particulates identified as fiberglass The recall status is ongoing. Affected quantity: 145,464 500mL bags.
Recall Details
- Product Type
- Drugs
- Report Date
- September 9, 2026
- Initiation Date
- August 17, 2026
- Termination Date
- N/A
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 145,464 500mL bags
Product Description
0.9% Sodium Chloride Injection USP 500 mL, VIAFLEX Plastic Containers, with 24 units per case. Baxter Healthcare Corporation, Deerfield, IL, 60015, USA, Made in USA, NDC 0338-0049-03
Reason for Recall
Presence of particulate matter: Particulates identified as fiberglass
Distribution Pattern
Natonwide in the USA
Code Information
Lot: Y495523, Y495523A, Exp 31-Oct-2027